CureVac N.V. (ETR:5CV)
Germany
· Delayed Price · Currency is EUR 4.702
-0.048 (-1.01%)
Jun 17, 2025, 9:44 AM CET
CureVac Market Cap
CureVac has a market cap or net worth of €1.07 billion as of June 16, 2025. Its market cap has increased by 37.53% in one year.
Market Cap
1.07B
Enterprise Value
698.53M
Revenue
523.70M
Ranking
n/a
PE Ratio
5.94
Stock Price
€4.70
Market Cap Chart
Since August 14, 2020, CureVac's market cap has decreased from 8.31B to 1.07B, a decrease of -87.10%. That is a compound annual growth rate of -34.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 16, 2025 | 1.07B | 45.17% |
| Dec 31, 2024 | 738.83M | -13.37% |
| Dec 29, 2023 | 852.88M | -20.54% |
| Dec 30, 2022 | 1.07B | -80.98% |
| Dec 31, 2021 | 5.64B | -51.75% |
| Dec 31, 2020 | 11.69B | 40.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 50.91B |
| Merck KGaA | 49.91B |
| Bayer Aktiengesellschaft | 27.00B |
| Fresenius SE & Co. KGaA | 24.78B |
| Fresenius Medical Care AG | 14.64B |
| Sartorius Aktiengesellschaft | 12.89B |
| Carl Zeiss Meditec AG | 5.35B |
| Fielmann Group AG | 4.54B |